ALACHUA, Fla., Aug. 02, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second quarter ended June 30, 2017.
Second Quarter 2017 Financial Results and Recent Business Highlights
Revenue of $15.2 million, up 46% compared to $10.4 million in the second quarter of 2016
Second Quarter 2017 Financial Results and Recent Business Highlights
Revenue of $15.2 million, up 46% compared to $10.4 million in the second quarter of 2016
